Director/PDMR Shareholding
Advanced Medical Solutions Group plc announced the effective grant of nil-cost share options to its Chief Executive Officer, Chris Meredith, for 422,941 shares, and to its Chief Financial Officer, Eddie Johnson, for 174,568 shares, under the Long Term Incentive Plan. These awards, previously approved, became effective today following the announcement of the recommended cash acquisition of AMS by H.B. Fuller Medical Adhesive Technologies Inc. The vesting of these options is contingent upon achieving specific Earnings Per Share and Total Shareholder Return performance criteria over three years, with recipients required to hold the shares for two years post-vesting.
Select text to share a quote on X · sign in to keep highlights & notes in your AMS notes
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces the award of nil-cost share options to the following Directors and persons discharging managerial responsibilities (PDMRs) of the Company (the "Awards") under the existing Advanced Medical Solutions Long Term Incentive Plan (the "LTIP").
The Awards were previously approved by the Company's Remuneration Committee and were due to be released in April 2026 in accordance with the Company's annual Executive remuneration cycle. Following today's publication of inside information in relation to the recommended cash acquisition of AMS by H.B. Fuller Medical Adhesive Technologies Inc. ("Bidco", a wholly-owned subsidiary of H.B. Fuller Company), the grant of the Awards has become effective today.
The vesting of these Awards is subject to the achievement of certain performance criteria for the three years prior to vesting. The performance criteria under the LTIP scheme is split equally between Earnings Per Share (EPS) achievement against target and Total Shareholder Return (TSR) against a comparator group. The recipients are required to hold the Awards for a period of two years following vesting.
Details of the impact of the Acquisition on all AMS Share Plans (including the Awards) and any associated proposals are summarised in the Co-operation Agreement between the Company and Bidco, and will be set out in the Scheme Document, and in separate letters to be sent to participants in all AMS Share Plans.
Capitalised terms used but not defined in this announcement have the same meaning as set out in today's announcement of the recommended cash acquisition of AMS by Bidco.
| PDMRs | AMS Shares subject to Awards granted |
|---|---|
| Chris Meredith, Chief Executive Officer | 422,941 |
| Eddie Johnson, Chief Financial Officer | 174,568 |
The notification below, made in accordance with the requirements of the Market Abuse Regulation no 596/2014 (incorporated into UK law by virtue of the European Union (Withdrawal) Act 2018 as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019), provides further detail.
| 1. | Details of the person discharging managerial responsibilities/person closely associated |
| a) | Name: Chris Meredith |
| 2. | Reason for the notification |
| a) | Position/status: Chief Executive Officer |
| b) | Initial notification/Amendment: Initial Notification |
| a) | Name: Advanced Medical Solutions Group plc |
| b) | LEI: 213800HJP6OWOSZI1L74 |
| a) | Description of the financial instrument, type of instrument: Options over ordinary Shares of 5p Identification code: GB0004536594 |
| b) | Nature of the transactions: - Grant of Awards under the Advanced Medical Solutions Long Term Incentive Plan 2014 |
| c) | Price(s) and volume(s): Price(s) Volume(s) - 422,941 |
| d) | Aggregated information: Aggregated volume: n/a Aggregated price: n/a |
| e) | Date of the transaction: 25 June 2026 |
| f) | Place of the transaction: Outside of a trading venue, XOFF |
| 1. | Details of the person discharging managerial responsibilities/person closely associated |
| a) | Name: Eddie Johnson |
| 2. | Reason for the notification |
| a) | Position/status: Chief Financial Officer |
| b) | Initial notification/Amendment: Initial Notification |
| a) | Name: Advanced Medical Solutions Group plc |
| b) | LEI: 213800HJP6OWOSZI1L74 |
| a) | Description of the financial instrument, type of instrument: Options over ordinary Shares of 5p Identification code: GB0004536594 |
| b) | Nature of the transactions: - Grant of Awards under the Advanced Medical Solutions Long Term Incentive Plan 2014 |
| c) | Price(s) and volume(s): Price(s) Volume(s) - 174,568 |
| d) | Aggregated information: Aggregated volume: n/a Aggregated price: n/a |
| e) | Date of the transaction: 25 June 2026 |
| f) | Place of the transaction: Outside of a trading venue, XOFF |
| Optimum Strategic Communications | Tel: +44 (0) 20 4566 8543 |
| Mary Clark / Nick Bastin / Isabelle Abdou | AMS@icrhealthcare.com |
| Investec Bank PLC (NOMAD & Broker) | Tel: +44 (0) 20 7597 5970 |
| Gary Clarence / Harry Hargreaves / Nick Prowting | |
| Berenberg (Joint Broker) | Tel: +44 (0)20 3207 7800 |
Toby Flaux / Detlir Elezi
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.